Monte Carlo Evaluation of Dose Enhancement Due to CuATSM or GNP Uptake in Hypoxic Environments with External Beam Radiation
Open Access
- 1 May 2020
- journal article
- research article
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. ume 15, 3719-3727
Abstract
Purpose: Most solid tumors contain areas of chronic hypoxia. Gold nanoparticles (GNP) have been extensively explored as enhancers of external beam radiation; however, GNP have lower cellular uptake in hypoxic conditions than under normoxic conditions. Conversely, the chelator diacetyl-bis (N(4)-methylthiosemicarbazonato) copper II (CuATSM) deposits copper in hypoxic regions, allowing for dose enhancement in previously inaccessible regions. Methods: External beam sources with different spectra were modeled using a Monte Carlo code (EGSnrc) to evaluate radioenhancement in a layered model with metal solutions. Also considered was a simple concentric layered tumor model containing a hypoxic core with each layer varying in concentrations of either copper or gold according to hypoxic conditions. Low energy external photon beams were then projected onto the tumor to determine the regional dose enhancement dependent on hypoxic conditions. Results: Dose enhancement was more pronounced for beam spectra with low energy photons (225 kVp) and was highly dependent on metal concentrations from 0.1 g/kg to 100 g/kg. Increasing the depth of the metallic solution layer from 1 cm to 6 cm decreased dose enhancement. A small increase in the dose enhancement factor (DEF) of 1.01 was predicted in the hypoxic regions of the tumor model with commonly used diagnostic concentrations of CuATSM. At threshold concentrations of toxic subcutaneous injection levels, the DEF increases to 1.02, and in simulation of a high concentration of CuATSM, the DEF increased to 1.07. High concentration treatments are also considered, as well as synergistic combinations of GNP/CuATSM treatments. Conclusion: The research presented is novel utilization of CuATSM to target hypoxic regions and act as a radiosensitizer by the nature of its ability to deposit copper metal in reduced tissue. We demonstrate CuATSM at high concentrations with low energy photons can increase dose deposition in hypoxic tumor regions.Keywords
This publication has 49 references indexed in Scilit:
- Gold nanoparticles as novel agents for cancer therapyBritish Journal of Radiology, 2012
- Targeted drug delivery to tumors: Myths, reality and possibilityJournal of Controlled Release, 2011
- Mechanism of cluster DNA damage repair in response to high-atomic number and energy particles radiationMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2011
- Internal radiotherapy with copper-64-diacetyl-bis (N4-methylthiosemicarbazone) reduces CD133+ highly tumorigenic cells and metastatic ability of mouse colon carcinomaNuclear Medicine and Biology, 2011
- Cell-Specific Radiosensitization by Gold Nanoparticles at Megavoltage Radiation EnergiesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Toxicity and cellular uptake of gold nanoparticles: what we have learned so far?Journal of Nanoparticle Research, 2010
- Some thoughts on the mechanism of cellular trapping of Cu(II)-ATSMNuclear Medicine and Biology, 2010
- A comprehensive system for dosimetric commissioning and Monte Carlo validation for the small animal radiation research platformPhysics in Medicine & Biology, 2009
- Cell line-dependent differences in uptake and retention of the hypoxia-selective nuclear imaging agent Cu-ATSMNuclear Medicine and Biology, 2005
- Basic characterization of 64Cu-ATSM as a radiotherapy agentNuclear Medicine and Biology, 2005